Stromal reactivity differentially drives tumour cell evolution and prostate cancer progression (Q94563067)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32393869 AND SRC:MED&resulttype=core&format=json

15 May 2020

title

Stromal reactivity differentially drives tumour cell evolution and prostate cancer progression (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32393869 AND SRC:MED&resulttype=core&format=json

15 May 2020

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32393869 AND SRC:MED&resulttype=core&format=json

15 May 2020

MinJae Lee

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32393869 AND SRC:MED&resulttype=core&format=json

15 May 2020

Simon W. Hayward

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32393869 AND SRC:MED&resulttype=core&format=json

15 May 2020

Alexander Anderson

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32393869 AND SRC:MED&resulttype=core&format=json

15 May 2020

author name string

Ziv Frankenstein

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32393869 AND SRC:MED&resulttype=core&format=json

15 May 2020

David Basanta

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32393869 AND SRC:MED&resulttype=core&format=json

15 May 2020

Omar E Franco

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32393869 AND SRC:MED&resulttype=core&format=json

15 May 2020

Yan Gao

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32393869 AND SRC:MED&resulttype=core&format=json

15 May 2020

Rodrigo A Javier

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32393869 AND SRC:MED&resulttype=core&format=json

15 May 2020

Gustavo Ayala

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32393869 AND SRC:MED&resulttype=core&format=json

15 May 2020

publication date

11 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32393869 AND SRC:MED&resulttype=core&format=json

Nature Ecology and Evolution

15 May 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32393869 AND SRC:MED&resulttype=core&format=json

Perspectives on tissue interactions in development and disease

15 May 2020

cites work

1 reference

https://api.crossref.org/works/10.1038/S41559-020-1157-Y

7 January 2021

The role of the basement membrane as a modulator of intestinal epithelial-mesenchymal interactions.

1 reference

https://api.crossref.org/works/10.1038/S41559-020-1157-Y

7 January 2021

Epithelial-stromal interactions in the mouse and human mammary gland in vivo

1 reference

https://api.crossref.org/works/10.1038/S41559-020-1157-Y

7 January 2021

Identification of fibroblast heterogeneity in the tumor microenvironment

1 reference

https://api.crossref.org/works/10.1038/S41559-020-1157-Y

7 January 2021

Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion

1 reference

https://api.crossref.org/works/10.1038/S41559-020-1157-Y

7 January 2021

Altered TGF-β signaling in a subpopulation of human stromal cells promotes prostatic carcinogenesis.

1 reference

https://api.crossref.org/works/10.1038/S41559-020-1157-Y

7 January 2021

Role for stromal heterogeneity in prostate tumorigenesis

1 reference

https://api.crossref.org/works/10.1038/S41559-020-1157-Y

7 January 2021

The role of tumor stroma in cancer progression and prognosis: emphasis on carcinoma-associated fibroblasts and non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1038/S41559-020-1157-Y

7 January 2021

Cellular Constituents of the Prostate Stroma: Key Contributors to Prostate Cancer Progression and Therapy Resistance

1 reference

https://api.crossref.org/works/10.1038/S41559-020-1157-Y

7 January 2021

Reprint of: Stromogenic prostatic carcinoma pattern (carcinomas with reactive stromal grade 3) in needle biopsies predicts biochemical recurrence-free survival in patients after radical prostatectomy

1 reference

https://api.crossref.org/works/10.1038/S41559-020-1157-Y

7 January 2021

Histologic features of stromogenic carcinoma of the prostate (carcinomas with reactive stroma grade 3).

1 reference

https://api.crossref.org/works/10.1038/S41559-020-1157-Y

7 January 2021

Determining prostate cancer-specific death through quantification of stromogenic carcinoma area in prostatectomy specimens

1 reference

https://api.crossref.org/works/10.1038/S41559-020-1157-Y

7 January 2021

Recruitment of CD34( ) fibroblasts in tumor-associated reactive stroma: the reactive microvasculature hypothesis.

1 reference

https://api.crossref.org/works/10.1038/S41559-020-1157-Y

7 January 2021

Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: the prostate cancer outcomes study.

1 reference

https://api.crossref.org/works/10.1038/S41559-020-1157-Y

7 January 2021

General quality of life 2 years following treatment for prostate cancer: what influences outcomes? Results from the prostate cancer outcomes study

1 reference

https://api.crossref.org/works/10.1038/S41559-020-1157-Y

7 January 2021

Natural history of progression after PSA elevation following radical prostatectomy

1 reference

https://api.crossref.org/works/10.1038/S41559-020-1157-Y

7 January 2021

Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy. The 15-year Johns Hopkins experience

1 reference

https://api.crossref.org/works/10.1038/S41559-020-1157-Y

7 January 2021

Cancer progression and survival rates following anatomical radical retropubic prostatectomy in 3,478 consecutive patients: long-term results

1 reference

https://api.crossref.org/works/10.1038/S41559-020-1157-Y

7 January 2021

Treatment of PSA only recurrence of prostate cancer after prior local therapy

1 reference

https://api.crossref.org/works/10.1038/S41559-020-1157-Y

7 January 2021

The role of transforming growth factor-beta-mediated tumor-stroma interactions in prostate cancer progression: an integrative approach

1 reference

https://api.crossref.org/works/10.1038/S41559-020-1157-Y

7 January 2021

Investigating prostate cancer tumour–stroma interactions: clinical and biological insights from an evolutionary game

1 reference

https://api.crossref.org/works/10.1038/S41559-020-1157-Y

7 January 2021

Fibroblasts contribute to melanoma tumor growth and drug resistance.

1 reference

https://api.crossref.org/works/10.1038/S41559-020-1157-Y

7 January 2021

Senescent fibroblasts in melanoma initiation and progression: an integrated theoretical, experimental, and clinical approach

1 reference

https://api.crossref.org/works/10.1038/S41559-020-1157-Y

7 January 2021

An integrated computational model of the bone microenvironment in bone-metastatic prostate cancer

1 reference

https://api.crossref.org/works/10.1038/S41559-020-1157-Y

7 January 2021

Integrating models to quantify environment mediated drug resistance

1 reference

https://api.crossref.org/works/10.1038/S41559-020-1157-Y

7 January 2021

Fibroblasts and alectinib switch the evolutionary games played by non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1038/S41559-020-1157-Y

7 January 2021

A hybrid model of tumor-stromal interactions in breast cancer.

1 reference

https://api.crossref.org/works/10.1038/S41559-020-1157-Y

7 January 2021

Tumour–stromal interactions in acid-mediated invasion: A mathematical model

1 reference

https://api.crossref.org/works/10.1038/S41559-020-1157-Y

7 January 2021

Histologic Grading of Prostatic Adenocarcinoma Can Be Further Optimized: Analysis of the Relative Prognostic Strength of Individual Architectural Patterns in 1275 Patients From the Canary Retrospective Cohort

1 reference

https://api.crossref.org/works/10.1038/S41559-020-1157-Y

7 January 2021

Mathematical modeling of cancer: the future of prognosis and treatment

1 reference

https://api.crossref.org/works/10.1038/S41559-020-1157-Y

7 January 2021

A hybrid mathematical model of solid tumour invasion: the importance of cell adhesion

1 reference

https://api.crossref.org/works/10.1038/S41559-020-1157-Y

7 January 2021

Hybrid models of tumor growth.

1 reference

https://api.crossref.org/works/10.1038/S41559-020-1157-Y

7 January 2021

Role of chemokines in tumor growth

1 reference

https://api.crossref.org/works/10.1038/S41559-020-1157-Y

7 January 2021

Immunity, Inflammation, and Cancer

1 reference

https://api.crossref.org/works/10.1038/S41559-020-1157-Y

7 January 2021

Expression of EZH2 and Ki-67 in colorectal cancer and associations with treatment response and prognosis

1 reference

https://api.crossref.org/works/10.1038/S41559-020-1157-Y

7 January 2021

Cross-talk between paracrine-acting cytokine and chemokine pathways promotes malignancy in benign human prostatic epithelium.

1 reference

https://api.crossref.org/works/10.1038/S41559-020-1157-Y

7 January 2021

Prognostic significance of the diameter of perineural invasion in radical prostatectomy specimens

1 reference

https://api.crossref.org/works/10.1038/S41559-020-1157-Y

7 January 2021

Prognostic value of Akt-1 in human prostate cancer: a computerized quantitative assessment with quantum dot technology

1 reference

https://api.crossref.org/works/10.1038/S41559-020-1157-Y

7 January 2021

High level of androgen receptor is associated with aggressive clinicopathologic features and decreased biochemical recurrence-free survival in prostate: cancer patients treated with radical prostatectomy

1 reference

https://api.crossref.org/works/10.1038/S41559-020-1157-Y

7 January 2021

Dangers of using "optimal" cutpoints in the evaluation of prognostic factors

1 reference

https://api.crossref.org/works/10.1038/S41559-020-1157-Y

7 January 2021

Global gene expression analysis of reactive stroma in prostate cancer.

1 reference

https://api.crossref.org/works/10.1038/S41559-020-1157-Y

7 January 2021

Fresh tissue harvest for research from prostatectomy specimens

1 reference

https://api.crossref.org/works/10.1038/S41559-020-1157-Y

7 January 2021

A method for checking regression models in survival analysis based on the risk score.

1 reference

https://api.crossref.org/works/10.1038/S41559-020-1157-Y

7 January 2021

Diagnostic plots to reveal functional form for covariates in multiplicative intensity models.

1 reference

https://api.crossref.org/works/10.1038/S41559-020-1157-Y

7 January 2021

Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker

1 reference

https://api.crossref.org/works/10.1038/S41559-020-1157-Y

7 January 2021

Derivation of androgen-independent human LNCaP prostatic cancer cell sublines: role of bone stromal cells

1 reference

https://api.crossref.org/works/10.1038/S41559-020-1157-Y

7 January 2021

10.1038/S41559-020-1157-Y

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32393869 AND SRC:MED&resulttype=core&format=json

15 May 2020

1 reference